Rankings
▼
Calendar
AKBA Q3 2019 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AKBA
Akebia Therapeutics, Inc.
$366M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$92M
+73.0% YoY
Gross Profit
$54M
58.4% margin
Operating Income
-$56M
-60.8% margin
Net Income
-$55M
-59.3% margin
EPS (Diluted)
$-0.46
QoQ Revenue Growth
-8.8%
Cash Flow
Operating Cash Flow
$11M
Free Cash Flow
$8M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$795M
Total Liabilities
$328M
Stockholders' Equity
$468M
Cash & Equivalents
$123M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$92M
$53M
+73.0%
Gross Profit
$54M
-$17M
+407.6%
Operating Income
-$56M
-$28M
-100.8%
Net Income
-$55M
-$26M
-109.6%
Revenue Segments
Product
$30M
100%
← FY 2019
All Quarters
Q4 2019 →